Failure of automatic mode switching: recognition and management

Area of Science:

• Cardiology
• Biomedical Engineering
• Electrophysiology

Background:

• Dual chamber pacing aims to improve AV synchrony and reduce supraventricular tachyarrhythmias.
• Patients with alternating bradycardia and supraventricular tachyarrhythmias present challenges for standard pacemakers.
• Automatic mode switching (AMS) algorithms prevent tracking of tachyarrhythmias to avoid adverse effects.

Purpose of the Study:

• To describe failures of the automatic mode switching algorithm in patients with paroxysmal supraventricular tachyarrhythmias.
• To investigate the role of antiarrhythmic drugs in pacemaker mode switching failures.
• To highlight the importance of appropriate pacemaker programming for specific patient populations.

Main Methods:

• Case series of seven patients with paroxysmal atrial flutter/fibrillation implanted with a Telectronics Meta DDDR 1254 pacemaker.
• Analysis of mode switching behavior during tachyarrhythmia episodes.
• Review of patient medication, specifically antiarrhythmic drugs affecting atrial cycle length.

Main Results:

• Seven patients experienced failure to mode switch or oscillation between atrial tracking and non-atrial tracking modes.
• Six patients were taking antiarrhythmic drugs that slowed their atrial cycle length.
• All seven patients required pacemaker reprogramming to restore reliable mode switching.

Conclusions:

• Failure to mode switch can occur with the Telectronics Meta DDDR 1254, particularly in patients with paroxysmal atrial flutter/fibrillation on antiarrhythmic drugs.
• Antiarrhythmic medications slowing atrial cycle length can impede sensing and lead to mode switching failures.
• Careful and individualized pacemaker programming is essential for optimal performance in patients with complex arrhythmia and pacing needs.